INCY logo

Incyte Corporation (INCY)

Profile

Full Name

Incyte Corporation

Ticker

NASDAQ: INCY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

November 4, 1993

Indexes

S&P 500

Website

https://www.incyte.com

Employees

2617

Key Details

Price

$85.46(+0.64%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.24B(+14.76% YoY)

Annual EPS

$0.15(-94.34% YoY)

PE ratio

19.42

Next earnings date

Oct 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $85.46
    INCY price is $85.46

    30-Day Relative Volume

    1.01
    INCY 30-day relative volume is 1.01

    Price Performance

    Price Today change

    +0.64%
    INCY price is up +0.64% today

    Price YTD change

    +23.73%
    INCY price is up +23.73% since January 1st

    Price 1-year change

    +35.09%
    INCY price is up +35.09% year-on-year

    Price 3-year change

    +14.65%
    INCY price is up +14.65% over the past 3 years

    Price Range

    Price All-time high

    $153.15
    INCY price is currently -44.20% below its historical high of $153.15

    Price 3-year low

    $50.27
    INCY price is currently +70.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $16.69B
    INCY market capitalization is $16.69 billion

    Market cap 3-year change

    +0.65%
    INCY market capitalization is up +0.65% over the past 3 years

    Market cap All-time high

    $28.96B
    INCY market capitalization is currently -42.37% below its historical high of $28.96 billion

    Market cap sector rank

    94.94%
    INCY market capitalization is higher than 94.94% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.39%
    INCY shares outstanding is up +1.39% year-on-year

    Shares Outstanding 3-Year Change

    -12.21%
    INCY shares outstanding is down -12.21% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.63
    INCY beta is 0.63

    200-day SMA

    $69.36
    INCY price is currently +23.21% above its 200-day simple moving average

    50-day SMA

    $72.58
    INCY price is currently +17.74% above its 50-day simple moving average

    RSI

    73.14
    INCY 14-day relative strength index is 73.14

    Volume

    1.01
    INCY 30-day relative volume is 1.01

    ATR

    $1.97
    INCY average true range is $1.97

    10-day Historical Volatility

    31.38%
    INCY 10-day historical volatility is 31.38%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.24B
    INCY annual revenue is $4.24 billion

    Revenue Analysts estimate

    $4.84B
    INCY annual revenue is currently -12.30% lower than the consensus analysts' forecast

    Revenue 1-year change

    +14.76%
    INCY annual revenue is up +14.76% year-on-year

    Revenue Sector rank

    93.49%
    INCY annual revenue is higher than 93.49% of companies in Healthcare sector

    EPS

    EPS

    $0.15
    INCY annual earnings per share is $0.15

    EPS Analysts estimate

    $6.09
    INCY annual earnings per share is currently -97.54% lower than the consensus analysts' forecast

    EPS 1-year change

    -94.34%
    INCY annual earnings per share is down -94.34% year-on-year

    EPS Sector rank

    84.63%
    INCY annual earnings per share is higher than 84.63% of companies in Healthcare sector

    Profit

    Gross profit

    $3.86B
    INCY annual gross profit is $3.86 billion

    Gross margin

    91.09%
    INCY annual gross profit margin is 91.09%

    Operating profit

    $101.29M
    INCY annual operating income is $101.29 million

    Operating margin

    2.39%
    INCY annual operating profit margin is 2.39%

    Net income

    $32.62M
    INCY annual net profit is $32.62 million

    Net margin

    0.77%
    INCY annual net profit margin is 0.77%

    Expenses

    Total expenses

    $4.14B
    INCY annual total expenses is $4.14 billion

    Operating expenses

    $3.83B
    INCY annual total operating expenses is $3.83 billion

    Cost of goods sold

    $377.72M
    INCY annual cost of goods sold is $377.72 million

    Selling, general & administrative expenses

    $1.22B
    INCY annual SGA is $1.22 billion

    Depreciation and amortization

    $89.25M
    INCY annual depreciation & amortization is $89.25 million

    Interest expense

    $0.00
    INCY annual interest expense is $0.00

    Income tax

    $284.01M
    INCY annual income tax is $284.01 million

    EBIT & EBITDA

    EBIT

    $318.91M
    INCY annual earnings before interest & taxes is $318.91 million

    EBITDA

    $408.16M
    INCY annual EBITDA is $408.16 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.48B
    INCY annual total assets is $5.48 billion

    Non current assets

    $2.24B
    INCY annual long term assets is $2.24 billion

    Current assets

    $3.24B
    INCY annual total current assets is $3.24 billion

    Cash and cash equivalents

    $1.69B
    INCY annual cash & cash equivalents is $1.69 billion

    Accounts receivable

    $853.15M
    INCY annual accounts receivable is $853.15 million

    Inventory

    $58.87M
    INCY annual inventory is $58.87 million

    Liabilities

    Total liabilities

    $2.03B
    INCY annual total liabilities is $2.03 billion

    Long term liabilities

    $392.84M
    INCY annual total long term liabilities is $392.84 million

    Current liabilities

    $1.64B
    INCY annual total current liabilities is $1.64 billion

    Accounts payable

    $197.47M
    INCY annual accounts payable is $197.47 million

    Debt

    Total debt

    $43.54M
    INCY annual total debt is $43.54 million

    Total debt 1-year change

    +13.73%
    INCY annual total debt is up +13.73% year-on-year

    Long term debt

    $33.54M
    INCY annual long term debt is $33.54 million

    Short term debt

    $10.00M
    INCY annual short term debt is $10.00 million

    Equity & Capital

    Shareholders equity

    $3.45B
    INCY annual stockholders equity is $3.45 billion

    Book value

    $3.45B
    INCY annual book value is $3.45 billion

    Retained earnings

    -$1.07B
    INCY annual retained earnings is -$1.07 billion

    Working capital

    $1.60B
    INCY annual working capital is $1.60 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $335.34M
    INCY annual cash flow from operations is $335.34 million

    Cash from operations 1-year change

    -32.46%
    INCY annual cash flow from operations is down -32.46% year-on-year

    Cash from investing

    $157.52M
    INCY annual cash flow from investing activities is $157.52 million

    Cash from investing 1-year change

    +175.85%
    INCY annual cash flow from investing activities is up +175.85% year-on-year

    Cash from financing

    -$2.02B
    INCY annual cash flow from financing activities is -$2.02 billion

    Cash from financing 1-year change

    -9991.08%
    INCY annual cash flow from financing activities is down -9991.08% year-on-year

    CAPEX

    CAPEX

    $100.16M
    INCY annual capital expenditures is $100.16 million

    CAPEX 1-year change

    +110.93%
    INCY annual capital expenditures is up +110.93% year-on-year

    Free Cash Flow

    Free cash flow

    $235.17M
    INCY annual free cash flow is $235.17 million

    Free cash flow 1-year change

    -47.62%
    INCY annual free cash flow is down -47.62% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    91.09%
    INCY annual gross profit margin is 91.09%

    Operating margin

    2.39%
    INCY annual operating profit margin is 2.39%

    Net margin

    0.77%
    INCY annual net profit margin is 0.77%

    ROA & ROE

    ROA

    0.53%
    INCY annual return on assets is 0.53%

    ROE

    0.76%
    INCY annual return on equity is 0.76%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    19.42
    INCY price to earnings ratio is 19.42

    PE ratio Sector rank

    40.38%
    INCY price to earnings ratio is higher than 40.38% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.00
    INCY price to book ratio is 4.00

    PB ratio Sector rank

    74.73%
    INCY price to book ratio is higher than 74.73% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.64
    INCY price to sales ratio is 3.64

    PS ratio Sector rank

    51.72%
    INCY price to sales ratio is higher than 51.72% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $14.78B
    INCY enterprise value is $14.78 billion

    Enterprise value Sector rank

    93.66%
    INCY enterprise value is higher than 93.66% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    10.90
    INCY EV/EBITDA is 10.90

    EV/EBITDA Sector rank

    84.22%
    INCY EV/EBITDA is higher than 84.22% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.97
    INCY annual current ratio is 1.97

    Quick ratio

    1.94
    INCY annual quick ratio is 1.94

    Leverage

    Debt to equity

    0.00
    INCY annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    INCY annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    7
    INCY piotroski f-score is 7

    Altman Z-Score

    5.96
    INCY altman z-score is 5.96

    Analyst ratings

    Recent major analysts updates

    Aug 6, 25 Wells Fargo
    Overweight
    Aug 1, 25 Barclays
    Overweight
    Jul 30, 25 Wells Fargo
    Equal-Weight
    Jul 30, 25 UBS
    Neutral
    Jul 30, 25 Truist Securities
    Hold
    Jul 30, 25 RBC Capital
    Sector Perform
    Jul 30, 25 Citigroup
    Buy
    Jul 30, 25 BMO Capital
    Underperform
    Jul 14, 25 JP Morgan
    Neutral
    Jun 16, 25 Stifel
    Buy

    Institutional Ownership

    Screeners with INCY included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    S&P 500 companies
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Incyte Corporation?
    • Does Incyte Corporation pay dividends?
    • What sector is Incyte Corporation in?
    • What industry is Incyte Corporation in?
    • What country is Incyte Corporation based in?
    • When did Incyte Corporation go public?
    • Is Incyte Corporation in the S&P 500?
    • Is Incyte Corporation in the NASDAQ 100?
    • Is Incyte Corporation in the Dow Jones?
    • When was Incyte Corporation's last earnings report?
    • When does Incyte Corporation report earnings?

    What is the ticker symbol for Incyte Corporation?

    The ticker symbol for Incyte Corporation is NASDAQ:INCY

    Does Incyte Corporation pay dividends?

    No, Incyte Corporation does not pay dividends

    What sector is Incyte Corporation in?

    Incyte Corporation is in the Healthcare sector

    What industry is Incyte Corporation in?

    Incyte Corporation is in the Biotechnology industry

    What country is Incyte Corporation based in?

    Incyte Corporation is headquartered in United States

    When did Incyte Corporation go public?

    Incyte Corporation's initial public offering (IPO) was on November 4, 1993

    Is Incyte Corporation in the S&P 500?

    Yes, Incyte Corporation is included in the S&P 500 index

    Is Incyte Corporation in the NASDAQ 100?

    No, Incyte Corporation is not included in the NASDAQ 100 index

    Is Incyte Corporation in the Dow Jones?

    No, Incyte Corporation is not included in the Dow Jones index

    When was Incyte Corporation's last earnings report?

    Incyte Corporation's most recent earnings report was on July 29, 2025

    When does Incyte Corporation report earnings?

    The next expected earnings date for Incyte Corporation is October 28, 2025
    On this page